Atlas Trials

Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

Clinical trial NCT05072691 · RECRUITING

Trial details

NCT number
NCT05072691
Sponsor
Francis Corazza
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2020-07-14
Primary completion
2030-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.